We investigated the importance of HGF, pMET and pAkt for the risk of ipsilateral breast tumour recurrence after adjuvant radiotherapy in primary breast cancer in tumours from the SweBCG91‐RT randomised trial. This evidence concerns the gene HGF and breast cancer.